Trials / Completed
CompletedNCT00932581
Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties
Investigation of the Psychometric Properties of the Bradykinesia Subscale When Administered Alone Versus as a Component of the Entire Motor Examination Section of the Unified Parkinson's Disease Rating Scale
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc. · Industry
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine whether scores on questionnaires that rate how much Parkinson's Disease (PD) has slowed movements of the body differ when the order of the questions are changed. The consistency and accuracy of the questionnaires will also be examined. It is hypothesized that there will not be a difference.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Bradykinesia UPDRS Motor Full Examination | The first group will receive the full motor examination section in its original order. |
| OTHER | Bradykinesia subscale of UPDRS Motor Examination | The second group will receive the bradykinesia subscale first followed by the remainder of the motor examination section. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-11-01
- Completion
- 2009-12-01
- First posted
- 2009-07-03
- Last updated
- 2023-04-07
Source: ClinicalTrials.gov record NCT00932581. Inclusion in this directory is not an endorsement.